Search
Stories, the companies and people Loro tracks, and the primary records behind them — filings, donations, contracts and disclosures.
Company or person7
AbCellera Biologics Inc.
Company
ADMA BIOLOGICS, INC.
Company
HCW Biologics Inc.
Company
Theriva Biologics, Inc.
Company
FibroBiologics, Inc.
Company
Atara Biotherapeutics, Inc.
Company
Bone Biologics Corp
Company
Primary record9
AbCellera Biologics Inc. filed 4
SEC form 4 filed by AbCellera Biologics Inc. (CIK 1703057) on 2026-08-24.
AbCellera Biologics Inc. filed 4
SEC form 4 filed by AbCellera Biologics Inc. (CIK 1703057) on 2026-08-18.
AbCellera Biologics Inc. filed 4
SEC form 4 filed by AbCellera Biologics Inc. (CIK 1703057) on 2026-08-14.
AbCellera Biologics Inc. filed 4
SEC form 4 filed by AbCellera Biologics Inc. (CIK 1703057) on 2026-08-14.
AbCellera Biologics Inc. filed 4
SEC form 4 filed by AbCellera Biologics Inc. (CIK 1703057) on 2026-08-13.
AbCellera Biologics Inc. filed 8-K
Item 1.01 Entry into a Material Definitive Agreement. On August 12, 2026, AbCellera Biologics Inc. (the Company ) entered into an underwriting agreement (the Underwriting Agreement ) with Jefferies LLC and J.P. Morgan Se
AbCellera Biologics Inc. filed 8-K
Item 7.01 Regulation FD On August 10, 2026, AbCellera Biologics Inc. (the Company ) issued a press release announcing positive top-line results from the Phase 2 portion of its Phase 1/2 clinical trial evaluating ABCL635,
AbCellera Biologics Inc. filed 8-K
Item 8.01 Other Events On August 7, 2026, AbCellera Biologics Inc. (the Company ) issued a press release announcing it will release top-line data from its Phase 2 trial evaluating ABCL635 for the treatment of moderate-to
AbCellera Biologics Inc. filed 8-K
Item 2.02 Results of Operations and Financial Condition On August 5, 2026, AbCellera Biologics Inc. (the Company ), issued a press release announcing its financial and operational results for the quarter ended June 30, 2